BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30770859)

  • 21. Promoting effects of MiR-135b on human multiple myeloma cells via regulation of the Wnt/β-catenin/Versican signaling pathway.
    Chen H; Zhao Y; Zhang J; Xie Y; Jin M
    Cytokine; 2021 Jun; 142():155495. PubMed ID: 33765653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R-spondin signalling is essential for the maintenance and differentiation of mouse nephron progenitors.
    Vidal VP; Jian-Motamedi F; Rekima S; Gregoire EP; Szenker-Ravi E; Leushacke M; Reversade B; Chaboissier MC; Schedl A
    Elife; 2020 May; 9():. PubMed ID: 32324134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
    Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
    Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
    Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway.
    Zhao JJ; Lin J; Zhu D; Wang X; Brooks D; Chen M; Chu ZB; Takada K; Ciccarelli B; Admin S; Tao J; Tai YT; Treon S; Pinkus G; Kuo WP; Hideshima T; Bouxsein M; Munshi N; Anderson K; Carrasco R
    Cancer Res; 2014 Mar; 74(6):1801-13. PubMed ID: 24599134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma.
    Arensman MD; Kovochich AN; Kulikauskas RM; Lay AR; Yang PT; Li X; Donahue T; Major MB; Moon RT; Chien AJ; Dawson DW
    Oncogene; 2014 Feb; 33(7):899-908. PubMed ID: 23416978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway.
    Geng W; Guo X; Zhang L; Ma Y; Wang L; Liu Z; Ji H; Xiong Y
    Biomed Pharmacother; 2018 Nov; 107():484-494. PubMed ID: 30107344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.
    Bjorklund CC; Ma W; Wang ZQ; Davis RE; Kuhn DJ; Kornblau SM; Wang M; Shah JJ; Orlowski RZ
    J Biol Chem; 2011 Apr; 286(13):11009-20. PubMed ID: 21189262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Wnt/β-catenin signaling pathway in the pathogenesis and treatment of multiple myeloma (review).
    Yuan Y; Guo M; Gu C; Yang Y
    Am J Transl Res; 2021; 13(9):9932-9949. PubMed ID: 34650674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WNT antagonist, DKK2, is a Notch signaling target in intestinal stem cells: augmentation of a negative regulation system for canonical WNT signaling pathway by the Notch-DKK2 signaling loop in primates.
    Katoh M; Katoh M
    Int J Mol Med; 2007 Jan; 19(1):197-201. PubMed ID: 17143565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
    Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
    Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
    Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
    Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
    Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
    Prosperi JR; Goss KH
    Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.
    Götze S; Wolter M; Reifenberger G; Müller O; Sievers S
    Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.
    Giuliani N; Morandi F; Tagliaferri S; Lazzaretti M; Donofrio G; Bonomini S; Sala R; Mangoni M; Rizzoli V
    Cancer Res; 2007 Aug; 67(16):7665-74. PubMed ID: 17702698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
    Schmeel FC; Schmeel LC; Kim Y; Schmidt-Wolf IG
    Hematol Oncol; 2014 Dec; 32(4):197-204. PubMed ID: 24470348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.